EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Menses, pregnancy, delivery, and menopause in hidradenitis suppurativa: A patient survey

Jennifer M Fernandez, Aleksi J Hendricks, Alyssa M Thompson, Elizabeth M Mata, Erin K Collier, Tristan R Grogan, Vivian Y Shi, Jennifer L Hsiao

International Journal of Women's Dermatology · 2020-12 · 6 (5) · 368-371

DOI: 10.1016/j.ijwd.2020.07.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Women's Dermatology, 2020-12. Verfasst von Jennifer M Fernandez und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Arizona, College of Medicine, Tucson, AZ, United States. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institutes of Health National Center for Advancing Translational Science, University of California Los Angeles Clinical and Translational Science Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hidradenitis suppurativa (HS) is a chronic inflammatory disorder that primarily affects women of childbearing age. There is a paucity of data on HS disease activity during menstruation, pregnancy, and menopause and the potential impact of HS on the method of delivery. OBJECTIVE: We aimed to characterize the natural history of HS symptoms during menses, pregnancy, and menopause. We also sought to evaluate the potential impact of HS on delivery method and whether there were delivery-related healing complications unique to women with HS. METHODS: An anonymous survey was distributed via social media to international HS support groups and patients at three HS specialty clinics in North America. Responses were collected from March to July 2019. RESULTS: A total of 279 respondents answered questions on disease changes during pregnancy. Menstruation caused worsening of HS symptoms in 76.7%, no change in 22.2%, and improvement in 1.1%. During pregnancy, the distribution between symptoms worsening (34.8%), having no change (28.7%), and improving (36.6%) was relatively even. After menopause, participants typically reported either worsening (39.5%) or no change (44.2%) in HS symptoms. Among respondents with anogenital HS involvement who delivered vaginally, 3.1% believed that HS interfered with vaginal delivery (VD), and 23.5% believed that VD caused an HS flare. Cesarean section (C-section) delivery was reported by 44.2% of participants. Ten participants reported that they were advised by their doctor to have a C-section instead of a VD because of severe anogenital HS. Of those who underwent a C-section, 33.9% reported that HS interfered with incision healing, and 51.2% reported developing new HS lesions in their C-section scar. CONCLUSION: To our knowledge, this is the first study describing the potential influence of HS on a patient's method of delivery. Multidisciplinary collaboration plays a pivotal role in developing individualized treatment and birth plans for pregnant women with HS.

Schlagwörter

Stichwörter der Autor:innen

Cesarean sectionDeliveryHidradenitis suppurativaMenopauseMensesPregnancy

Autor:innen und Institutionen

  • University of Arizona, College of Medicine, Tucson, AZ, United States.
  • University of California Los Angeles, David Geffen School of Medicine, Los Angeles, CA, United States.
  • Department of Medicine Statistics Core, David Geffen School of Medicine, University of California, Los Angeles, CA, United States.
  • Department of Medicine, Division of Dermatology, University of Arizona, Tucson, AZ, United States.
  • Department of Medicine, Division of Dermatology, University of California Los Angeles, Los Angeles, CA, United States.

Förderung

  • National Institutes of Health National Center for Advancing Translational Science
  • University of California Los Angeles Clinical and Translational Science Institute

Zitieren

APA

Fernandez, J. M., Hendricks, A. J., Thompson, A. M., Mata, E. M., Collier, E. K., Grogan, T. R., Shi, V. Y., & Hsiao, J. L. (2020). Menses, pregnancy, delivery, and menopause in hidradenitis suppurativa: A patient survey. International Journal of Women's Dermatology, 6(5), 368-371. https://doi.org/10.1016/j.ijwd.2020.07.002

Vancouver

Fernandez JM, Hendricks AJ, Thompson AM, Mata EM, Collier EK, Grogan TR, et al. Menses, pregnancy, delivery, and menopause in hidradenitis suppurativa: A patient survey. International Journal of Women's Dermatology. 2020;6(5):368-371. doi:10.1016/j.ijwd.2020.07.002

BibTeX
@article{Fernandez2020,
  author = {Fernandez, Jennifer M and Hendricks, Aleksi J and Thompson, Alyssa M and Mata, Elizabeth M and Collier, Erin K and Grogan, Tristan R and Shi, Vivian Y and Hsiao, Jennifer L},
  title = {Menses, pregnancy, delivery, and menopause in hidradenitis suppurativa: A patient survey},
  journal = {International Journal of Women's Dermatology},
  year = {2020},
  volume = {6},
  number = {5},
  pages = {368--371},
  doi = {10.1016/j.ijwd.2020.07.002}
}
Kostenlos starten →